Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Schibsted in conjunction with sale of shares in Hitta.se
Mandate

Vinge advises Schibsted in conjunction with sale of shares in Hitta.se

July 18, 2017

Vinge has advised Schibsted in conjunction with the sale of 90.2 per cent of the shares in Hitta.se.

The buyers are Alexander Hannerland and Stefan Tocca, both with a background in Hitta.se and Schibsted respectively, as well as Sprints Capital Management, a London based investment company founded by Henrik Persson. Last year, Hitta.se’s turnover was MSEK 257 with an EBITDA of MSEK 69.

Vinge’s team consisted of partners Johan Winnerblad and Kristina Ekberg together with associates Louise Nordkvist and Jonas Borg.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026